Growth Metrics

Biocryst Pharmaceuticals (BCRX) Shares Outstanding (Weighted Average): 2010-2015

Historic Shares Outstanding (Weighted Average) for Biocryst Pharmaceuticals (BCRX) over the last 5 years, with Sep 2015 value amounting to $73.2 million.

  • Biocryst Pharmaceuticals' Shares Outstanding (Weighted Average) rose 2.07% to $73.2 million in Q3 2015 from the same period last year, while for Sep 2015 it was $73.2 million, marking a year-over-year increase of 2.07%. This contributed to the annual value of $71.9 million for FY2014, which is 21.61% up from last year.
  • Latest data reveals that Biocryst Pharmaceuticals reported Shares Outstanding (Weighted Average) of $73.2 million as of Q3 2015, which was up 0.99% from $72.5 million recorded in Q2 2015.
  • Biocryst Pharmaceuticals' 5-year Shares Outstanding (Weighted Average) high stood at $73.2 million for Q3 2015, and its period low was $45.1 million during Q2 2011.
  • Moreover, its 3-year median value for Shares Outstanding (Weighted Average) was $60.1 million (2014), whereas its average is $63.5 million.
  • Data for Biocryst Pharmaceuticals' Shares Outstanding (Weighted Average) shows a peak YoY soared of 32.30% (in 2014) over the last 5 years.
  • Over the past 5 years, Biocryst Pharmaceuticals' Shares Outstanding (Weighted Average) (Quarterly) stood at $45.2 million in 2011, then grew by 12.53% to $50.9 million in 2012, then climbed by 16.14% to $59.1 million in 2013, then climbed by 21.61% to $71.9 million in 2014, then rose by 2.07% to $73.2 million in 2015.
  • Its Shares Outstanding (Weighted Average) was $73.2 million in Q3 2015, compared to $72.5 million in Q2 2015 and $72.3 million in Q1 2015.